跳至主要内容
临床试验/TCTR20161213001
TCTR20161213001尚未招募4 期

Comparison of the therapeutic effects of levetiracetam and sodium valproate on the containment of migraine headaches

Azad Islamic University0 个研究点目标入组 52 人开始时间: 2016年12月13日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Inclusion criteria included: diagnosis of migraine based on the criteria of International Headache Society, 6 months of migraine attacks with auras, and no history of diseases that are compounded with headaches, consumption of prophylaxis for migraine in last 6 months.

排除标准

  • drugs leading to headaches including Nitrogen compounds, oral contraceptive pills and alcohol. Patients who were not interested in the study, or the prescribed medicine was not effective in them, were discarded from the study

研究者

相似试验